Elegant Chemical Enterprises Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 24-07-2024
- Paid Up Capital ₹ 9.43 M
as on 24-07-2024
- Company Age 42 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.75 M
as on 24-07-2024
- Revenue -16.51%
(FY 2023)
- Profit -270.48%
(FY 2023)
- Ebitda -65.65%
(FY 2023)
- Net Worth -14.39%
(FY 2023)
- Total Assets -14.10%
(FY 2023)
About Elegant Chemical Enterprises
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.43 M.
The company currently has active open charges totaling ₹1.75 M.
Ashwini Chadda and Vikram Dhawan serve as directors at the Company.
- CIN/LLPIN
U24110TG1982PTC003515
- Company No.
003515
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jul 1982
- Date of AGM
04 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Elegant Chemical Enterprises Pvt Ltd offer?
Elegant Chemical Enterprises Pvt Ltd offers a wide range of products and services, including Ayurvedic, Herbal Oils and Cosmetics, Ayurvedic Cosmetics, Pharmaceutical Syrup, Oral Suspension, Pharmaceutical Machines, Tablet Making Machines.
Who are the key members and board of directors at Elegant Chemical Enterprises?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwini Chadda  | Director | 18-Mar-2002 | Current |
| Vikram Dhawan | Director | 08-Oct-2005 | Current |
Financial Performance of Elegant Chemical Enterprises.
Elegant Chemical Enterprises Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.51% decrease. The company also saw a substantial fall in profitability, with a 270.48% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elegant Chemical Enterprises?
In 2023, Elegant Chemical Enterprises had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Andhra Bank Creation Date: 24 May 1995 | ₹0.55 M | Open |
Indian Bank Creation Date: 31 Aug 1987 | ₹1.20 M | Open |
How Many Employees Work at Elegant Chemical Enterprises?
Elegant Chemical Enterprises has a workforce of 48 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elegant Chemical Enterprises, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elegant Chemical Enterprises's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
